4C Medical Technologies, Inc. announced that it has received $60,611,131.0831 in a round of funding on November 4, 2021. The transaction was led by returning investor MicroPort CardioFlow Medtech Corporation for up to $35,400,000, and included participation from other investors. The company expected to received $44,999,999 in the transaction.

The company issued 13,063,715 series C-1 preferred shares at issue price of $3.8357 per share for the gross proceeds $50,108,491.6255 and 3,422,616 series C-2 preferred shares at issue price of $3.0686 per share for the gross proceeds $10,502,639.4576 in the transaction. The shares will be convertible in common shares at a fixed conversion price of $3.8357 and $3.0686 per share respectively. The company has received $19,639,664 pursuant to exemption provided under Regulation D from 53 investors.